Key Findings

🍽️ Cancer Cells That Stick Around Get 'Nibbled' Instead of Eaten

Immune cells called macrophages face a choice when attacking cancer: swallow the whole cell (phagocytosis) or just take small bites (trogocytosis). Researchers found that when cancer cells are firmly stuck to surfaces or each other, macrophages switch to nibbling mode instead of eating them whole. When they disrupted cancer cell adhesion or caught cells during division (when they're naturally less sticky), macrophages went back to full consumption.

🧠 Brain Cancer Resistance Cracked with Tea Compound

Using CRISPR screening of 1,117 genes, researchers identified FBXO5 as a key driver of resistance to temozolomide, a standard brain cancer drug. High FBXO5 levels correlated with poor treatment response and reduced survival. They discovered a tea compound called Theaflavin 3,3'-digallate (TF3) that blocks FBXO5 and synergistically improves drug sensitivity both in lab studies and animal models.

🧬 Breast Cancer Cells Show Distinct RNA Modification Patterns

Scientists used advanced sequencing to map m6A modifications (chemical tags on RNA) across five breast cancer cell lines. They found that different cancer subtypes have dramatically different modification patterns: MCF-7 and BT-474 cells were mostly under-modified, while BT-20, MDA-MB-231 and SK-BR-3 cells showed widespread over-modification. These patterns could explain some of the diversity seen in breast cancer behavior.

💊 Cholesterol Transport Protein Emerges as Heart Disease Target

Through large-scale CRISPR screening, researchers identified ABCC4 as a key regulator of cholesterol clearance. When they blocked ABCC4 in liver cells, it increased levels of LDL receptors (the 'good' cholesterol cleaners) and reduced blood cholesterol. The mechanism works through a cAMP signaling pathway that ultimately prevents the breakdown of these important cholesterol-clearing receptors.

🔥 Liver Cancer's Defense Against Cell Death Pathway Revealed

Researchers used CRISPR screening to discover how liver cancer resists ferroptosis (a type of cell death involving iron). They found that JMJD6 protein helps cancer cells survive by activating a PPAR𝛾-GPX4 pathway that clears away toxic lipid damage. When they combined JMJD6 inhibitors with existing drugs like sorafenib or lenvatinib, it dramatically enhanced cancer cell death both in lab studies and animal models.

🌱 Cotton Seeds Made Safer by Reducing Toxic Compound

Scientists used CRISPR to knock out the GhCAD gene in cotton plants, reducing gossypol content by approximately 64% in cottonseeds and leaves. When only one version of the gene was edited, seed gossypol dropped by about 46% with no major changes in leaves. The modified seeds maintained their normal protein and fatty acid profiles, making them potentially safer for food and feed applications.